Skip to Content
Merck
CN
  • Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling.

Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling.

PloS one (2017-12-06)
Erin Williams, Alejandro Villar-Prados, Jessica Bowser, Russell Broaddus, Andrew B Gladden
ABSTRACT

Cell adhesion and apicobasal polarity together maintain epithelial tissue organization and homeostasis. Loss of adhesion has been described as a prerequisite for the epithelial to mesenchymal transition. However, what role misregulation of apicobasal polarity promotes tumor initiation and/or early progression remains unclear. We find that human low-grade endometrial cancers are associated with disrupted localization of the apical polarity protein Par3 and Ezrin while, the adhesion molecule E-cadherin remains unchanged, accompanied by decreased Notch signaling, and altered Notch receptor localization. Depletion of Par3 or Ezrin, in a cell-based model, results in loss of epithelial architecture, differentiation, increased proliferation, migration and decreased Notch signaling. Re-expression of Par3 in endometrial cancer cell lines with disrupted Par3 protein levels blocks proliferation and reduces migration in a Notch dependent manner. These data uncover a function for apicobasal polarity independent of cell adhesion in regulating Notch-mediated differentiation signals in endometrial epithelial cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
Monoclonal Anti-β-Tubulin I antibody produced in mouse, clone SAP.4G5, ascites fluid
Sigma-Aldrich
Anti-Partitioning-defective 3 Antibody, Upstate®, from rabbit
Sigma-Aldrich
Monoclonal Anti-Tubulin, Acetylated antibody produced in mouse, clone 6-11B-1, ascites fluid